Erythropoietin receptor and hematological disease

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


This review will discuss evidence for the role of the erythropoietin (Epo) receptor in the development of erythrocytosis and other hematological disorders, The possible causative role of mutations of other genes in the pathogenesis of idiopathic erythrocytosis will be considered, Polycythemia vera (PV) is a myeloproliferative disorder that is caused by an undefined stem cell abnormality, characterized by a significant erythrocytosis, leukocytosis, and thrombocytosis. However, erythrocytosis may arise from apparent (or relative) polycythemia in which the hematocrit is raised due to a low plasma volume. In such cases the red cell mass is normal. A group of disorders with increased red cell mass caused by stimulation of erythrocyte production is known as secondary polycythemia, Investigation of such patients may reveal a congenital abnormality such as high affinity hemoglobin or an acquired abnormality caused, for example, by smoking, renal Vascular impairment, or an Epo-producing tumor. Even after thorough examination there remains a cohort of patients for whom no definite cause for the erythrocytosis can be established, A careful clinical history may reveal whether this idiopathic erythrocytosis is likely to be congenital and/or familial, in which case the term
Original languageEnglish
Pages (from-to)55-60
Number of pages6
JournalAmerican Journal of Hematology
Issue number1
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Erythropoietin receptor and hematological disease'. Together they form a unique fingerprint.

Cite this